. . . . . . . . . "novolog mix 7 3 is an insulin analog indicated to improve glycemic control in patients with diabetes mellitus important limitations of use in premix insulins such as novolog mix 7 3 the proportions of rapid acting and long acting insulins are fixed and do not allow for basal versus prandial dose adjustments novolog mix 7 3 is an insulin analog indicated to improve glycemic control in patients with diabetes mellitus important limitations of use in premix insulins such as novolog mix 7 3 the proportions of rapid acting and long acting insulins are fixed and do not allow for basal versus prandial dose adjustments 1" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "NhlSxi68i6MCQcK72x4La4U4ksTeHO0OnaSsmvDxrpL8kxVUdoGQ2k79mVDyS4wsw+VCSZBjc1pLqm96ZkSriBvGDxKSpQJX+QCZS6+D/tZ/nAFkHVcKLm4Pgt2eaCkoizFV4NqQ0w3PVEqxBsGQXlF6LXAoRUdyrbkcZy6WV2s=" . . "2021-07-03T15:25:09.917+02:00"^^ . . . . .